• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Topics » Analysis and data insight

Analysis and data insight
Analysis and data insight RSS Feed RSS

Week in review for March 2-6, 2020: Financial markets in freefall

March 9, 2020
By Peter Winter
A quick look back at top stories.
Read More

Money raised by biopharma: 2020 vs. 2019

March 6, 2020
Total raised in public, private and other financings of biopharma companies, comparing 2020 vs. 2019.
Read More

Biopharma money raised: Jan. 1-March 5, 2020

March 6, 2020
Year-to-date money raised in public, private and other financings of biopharma companies.
Read More
Wall Street sign

Completed and pending biopharma IPOs in February 2020

March 6, 2020
Completed and pending initial public offerings by biopharma companies, including: 4D Molecular, Akeso, Beam, Bio-Thera, Continent, Frontier, Hutchison China Meditech, Imara, Immunotech, Innocare, NLS, Oric, Passage Bio, Revolution Medicines, Scilex, Shanghai Shenlian, Tasly.
Read More

Follow-on offerings of biopharma companies in February 2020

March 6, 2020
Follow-ons completed by biopharma companies, including: Adma, Adverum, Agile, Appili, Applied Genetic Technologies, Atyr, Avrobio, Axovant Gene, Bioxcel, Briacell, Can-Fite, Catalyst, Collegium, Deciphera, Diamedica, Eyepoint, Fortress, Intec, Kezar Life Sciences, Miragen, Moderna, Novan, Oramed, PDS, Phio, Polarityte, Rapt, Rockwell Medical, Salarius, Seelos, Theravance, Tonix, Xeris, Ziopharm, Zosano.
Read More

Other financings of public biotechnology companies in February 2020

March 6, 2020
Private placements and other private financings of public biopharma companies, including: Acerus, Adamis, Aeterna Zentaris, Agile, Algernon, Alimera, Aptorum, Arch, Armata, Avadel, Biomerica, Cidara, Cocrystal, Collegium, Collplant, Cortexyme, CTI, Curis, Daré, Enlivex, E-therapeutics, Genmab, Genprex, Hemostemix, Kali-Extracts, Lidds, Lipocine, Mereo, Moleculin, Navidea, Novacyt, Orphazyme, Outlook, Phio, Promis, Redhill, Redx, Revance, Revive, Spero, Syndax, Syros, Valneva, Vaxil, Xortx, Zelira.
Read More

Venture capital and other private biopharma financings in February 2020

March 6, 2020
Venture capital and other private financings of private biopharma companies, including: Aivita, Alladapt, Alx Oncology, Aurora Science, Azafaros, Canbridge, Ikarovec, Inotrem, Kahr Medical, Kaipharm, Maat Pharma, Neotx, Novelty Nobility, Omass, Oncodna, Pentixapharm, Pinpoint, Sonoma, Spruce Biosciences, Valo, Volastra.
Read More

Milestone payments from corporate partners in February 2020

March 6, 2020
Triggered milestone payments disclosed by biopharma companies, including:Aduro, Alvogen Korea, Arecor, Basilea, Bristol-Myers Squibb, Cytomx, Eurofarma Laboratórios, Merck & Co., Molecular Templates, Oncodesign, Pfizer, Servier, Summit, Takeda, Vivus.
Read More

Med-tech gainers and losers for March 2-6, 2020

March 6, 2020
The top 10 med-tech stock gainers and losers for the week.
Read More
Coronavirus and DNA

Industry, academia pivot: Pipeline of COVID-19 vaccine and therapeutic candidates doubles

March 6, 2020
By Karen Carey
A list of biopharma companies and nonprofit entities, including academia, working feverishly to find a vaccine or antiviral treatment to address the rapidly spreading coronavirus, now known as COVID-19, has more than doubled, increasing from about 30 a few weeks ago to 71 as of March 6.
Read More
Previous 1 2 … 234 235 236 237 238 239 240 241 242 … 264 265 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 18, 2025.
  • BIO2025: John Crowley and Martin Makary

    BIO 2025: Makary lays out FDA’s path, launches pilot review program

    BioWorld
    On the same day that FDA Commissioner Martin Makary spoke in a fireside chat during the 2025 Biotechnology Innovation Organization’s International Convention, the...
  • Stock chart, upward arrow

    An early stage 85% remissions rate in AML drives Aptevo’s stock surge

    BioWorld
    An 85% remissions rate was found in updated results from Aptevo Therapeutics Inc.’s ongoing phase Ib/II Ranier study of mipletamig in one of the toughest blood...
  • 3D illustration of a chain of amino acid or biomolecules called protein

    Alphadesign: AI creating proteins from scratch

    BioWorld Science
    The Alphafold machine learning system for predicting a protein’s structure from its amino acid sequence has been adapted to make it possible to design de novo...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe